These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 22433994)

  • 21. Proposed core set of outcome measures in patients with primary Sjögren's syndrome: 5 year follow up.
    Theander E; Andersson SI; Manthorpe R; Jacobsson LT
    J Rheumatol; 2005 Aug; 32(8):1495-502. PubMed ID: 16078325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peak exercise capacity estimated from incremental shuttle walking test in patients with COPD: a methodological study.
    Arnardóttir RH; Emtner M; Hedenström H; Larsson K; Boman G
    Respir Res; 2006 Oct; 7(1):127. PubMed ID: 17044921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk-adjusted outcome models for public mental health outpatient programs.
    Hendryx MS; Dyck DG; Srebnik D
    Health Serv Res; 1999 Apr; 34(1 Pt 1):171-95. PubMed ID: 10201857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical algorithm for improved prediction of ambulation and patient stratification after incomplete spinal cord injury.
    Zörner B; Blanckenhorn WU; Dietz V; ; Curt A
    J Neurotrauma; 2010 Jan; 27(1):241-52. PubMed ID: 19645527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical functioning in patients with chronic kidney disease.
    Padilla J; Krasnoff J; Da Silva M; Hsu CY; Frassetto L; Johansen KL; Painter P
    J Nephrol; 2008; 21(4):550-9. PubMed ID: 18651545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JAMA Oncology Patient Page. Performance Status in Patients With Cancer.
    West HJ; Jin JO
    JAMA Oncol; 2015 Oct; 1(7):998. PubMed ID: 26335750
    [No Abstract]   [Full Text] [Related]  

  • 27. The Palliative Performance Scale #125.
    Wilner LS; Arnold RM
    J Palliat Med; 2006 Aug; 9(4):994. PubMed ID: 16910815
    [No Abstract]   [Full Text] [Related]  

  • 28. Reporting functional status in UNOS: The weakness of the Karnofsky Performance Status Scale.
    Wang CW; Lai JC
    Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28580753
    [No Abstract]   [Full Text] [Related]  

  • 29. Outside the (Pill)box: Can Physician Performance be Assessed by Objective Measures?
    Bajaj S
    Virtual Mentor; 2007 Jul; 9(7):494-6. PubMed ID: 23218106
    [No Abstract]   [Full Text] [Related]  

  • 30. Smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase I/II clinical trials.
    Douma JAJ; Zweegman S; Alberts M; Kruyswijk S; van de Donk NCWJ; van Linde M; Buffart LM; Verheul HMW
    Support Care Cancer; 2021 Jul; 29(7):3783-3792. PubMed ID: 33236210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are patient-reported outcomes of physical function a valid substitute for objective measurements?
    Douma JAJ; Verheul HMW; Buffart LM
    Curr Oncol; 2018 Oct; 25(5):e475-e479. PubMed ID: 30464699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility, validity and reliability of objective smartphone measurements of physical activity and fitness in patients with cancer.
    Douma JAJ; Verheul HMW; Buffart LM
    BMC Cancer; 2018 Oct; 18(1):1052. PubMed ID: 30373549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe sarcopenia might be associated with a decline of physical independence in older patients undergoing chemotherapeutic treatment.
    Rier HN; Jager A; Meinardi MC; van Rosmalen J; Kock MCJM; Westerweel PE; Trajkovic M; Sleijfer S; Levin MD
    Support Care Cancer; 2018 Jun; 26(6):1781-1789. PubMed ID: 29247308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of physical performance measurements alongside assessment of sarcopenia in predicting receipt and completion of planned treatment in non-small cell lung cancer: an observational exploratory study.
    Collins JT; Noble S; Chester J; Davies HE; Evans WD; Farewell D; Lester JF; Parry D; Pettit R; Byrne A
    Support Care Cancer; 2018 Jan; 26(1):119-127. PubMed ID: 28721555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of sarcopenia and observed physical performance with attainment of multidisciplinary team planned treatment in non-small cell lung cancer: an observational study protocol.
    Collins JT; Noble S; Chester J; Davies HE; Evans WD; Lester J; Parry D; Pettit RJ; Byrne A
    BMC Cancer; 2015 Jul; 15():544. PubMed ID: 26204885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The assessment and impact of sarcopenia in lung cancer: a systematic literature review.
    Collins J; Noble S; Chester J; Coles B; Byrne A
    BMJ Open; 2014 Jan; 4(1):e003697. PubMed ID: 24384894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Objective measures of physical functional capacity warrant exploration to complement or replace the subjective physician estimated performance status.
    Sonpavde G; Vogelzang NJ; Galsky MD; Raghavan VA; Daniel S
    Am J Clin Oncol; 2012 Apr; 35(2):163-6. PubMed ID: 22433994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of functional and health status measures in heart failure.
    Myers J; Zaheer N; Quaglietti S; Madhavan R; Froelicher V; Heidenreich P
    J Card Fail; 2006 Aug; 12(6):439-45. PubMed ID: 16911910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease?
    Kanwal F; Hays RD; Kilbourne AM; Dulai GS; Gralnek IM
    Am J Gastroenterol; 2004 Sep; 99(9):1726-32. PubMed ID: 15330910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures.
    Gijbels D; Alders G; Van Hoof E; Charlier C; Roelants M; Broekmans T; Eijnde BO; Feys P
    Mult Scler; 2010 May; 16(5):618-26. PubMed ID: 20207785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.